Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

257
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
257
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

215
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
215
Alcohols from Carbonyl Compounds: Reduction02:23

Alcohols from Carbonyl Compounds: Reduction

12.1K
Reduction is a simple strategy to convert a carbonyl group to a hydroxyl group. The three major pathways to reduce carbonyls to alcohols are catalytic hydrogenation, hydride reduction, and borane reduction.
Catalytic hydrogenation is similar to the reduction of an alkene or alkyne by adding H2 across the pi bond in the presence of transition metal catalysts like Raney Ni, Pd–C, Pt, or Ru. Aldehydes and ketones can be reduced by this method, often under mild to moderate heat (25–100°C) and...
12.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

1.0K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using Gene Expression Changes for Monitoring Glioblastoma WHO CNS Grade 4 Recurrence: Validation of NGS Candidate Genes via qRT-PCR.

Radiation research·2026
Same author

Development of a Point-of-Care Microfluidic RNA Extraction Slide for Gene Expression Diagnosis after Irradiation.

Radiation research·2024
Same author

Applicability of Gene Expression in Saliva as an Alternative to Blood for Biodosimetry and Prediction of Radiation-induced Health Effects.

Radiation research·2024
Same author

Validating a Four-gene Set for H-ARS Severity Prediction in Peripheral Blood Samples of Irradiated Rhesus Macaques.

Radiation research·2024
Same author

PUM1 and PGK1 are Favorable Housekeeping Genes over Established Biodosimetry-related Housekeeping Genes such as HPRT1, ITFG1, DPM1, MRPS5, 18S rRNA and Others after Radiation Exposure.

Radiation research·2024
Same author

Validating Radiosensitivity with Pre-Exposure Differential Gene Expression in Peripheral Blood Predicting Survival and Non-Survival in a Second Irradiated Rhesus Macaque Cohort.

Radiation research·2024
Same journal

Opioid Message Fatigue in the United States: Prevalence and Associations with Stigma and Policy Support.

Substance use & misuse·2026
Same journal

Why Participants Leave: A Qualitative Study Exploring Dropout from a Medication for Opioid Use Disorder (MOUD) Clinical Trial.

Substance use & misuse·2026
Same journal

Reasons for Discontinuation and Associated Factors in Opioid Agonist Treatment: A Community-Based Study from India.

Substance use & misuse·2026
Same journal

Understanding Daily Cannabis Use among Young Adults in Post-Legalization Québec: Motivations, Consumption Practices, and Control Strategies.

Substance use & misuse·2026
Same journal

Bidirectional Associations Between Alcohol and Tobacco Use in Adults: A Systematic Review of Quantitative Studies on Reciprocal Influences.

Substance use & misuse·2026
Same journal

An Exploration of Narrative and Dynamic Norm Messages for Discouraging Vaping Among Young Adults.

Substance use & misuse·2026
See all related articles

Related Experiment Video

Updated: Jan 18, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.7K

Reducing Alcohol Use Among Patients with Hepatitis C.

A Giannopoulos1, J C Elliott1, N Viscaino1

  • 1Molloy University1000 Hempstead Avenue, Rockville CentreNY11570.

Substance Use & Misuse
|January 16, 2026
PubMed
Summary
This summary is machine-generated.

Psychosocial interventions effectively reduce alcohol consumption in individuals with chronic Hepatitis C Virus (HCV) and HIV/HCV co-infection. These interventions improve abstinence rates and engagement in alcohol treatment, benefiting overall health.

Keywords:
Alcohol InterventionsHIV/HCV co-infectionHepatitis CSubstance Use

More Related Videos

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
10:42

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

Published on: May 13, 2016

9.5K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.0K

Related Experiment Videos

Last Updated: Jan 18, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.7K
Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
10:42

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

Published on: May 13, 2016

9.5K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.0K

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Addiction Medicine

Background:

  • Heavy alcohol use poses significant risks for individuals with chronic Hepatitis C Virus (HCV) infection.
  • Co-infection with human immunodeficiency virus (HIV) and HCV exacerbates these risks, potentially leading to severe liver damage and mortality.
  • These populations have historically received insufficient clinical attention regarding alcohol use management.

Purpose of the Study:

  • To systematically review and synthesize existing literature on alcohol interventions for individuals with chronic HCV.
  • To specifically examine interventions tailored for the HIV/HCV co-infected population.
  • To build upon and update previous reviews on this topic.

Main Methods:

  • A comprehensive literature search was conducted to identify relevant studies.
  • Included studies evaluated the efficacy of drinking reduction interventions.
  • Studies focused on populations with chronic HCV and those with HIV/HCV co-infection.

Main Results:

  • Seven studies met the inclusion criteria: four for HCV and three for HIV/HCV co-infection.
  • Participants showed significant positive responses to interventions.
  • Key outcomes included increased abstinence rates, reduced alcohol consumption, fewer heavy drinking days, and enhanced treatment engagement.

Conclusions:

  • Psychosocial interventions show promise in reducing alcohol use among individuals with chronic HCV and HIV/HCV co-infection.
  • Successfully reducing alcohol intake is a critical behavioral change with positive implications for patient health.
  • Further research and clinical attention are warranted for these vulnerable populations.